JPWO2021177333A1 - - Google Patents

Info

Publication number
JPWO2021177333A1
JPWO2021177333A1 JP2022504415A JP2022504415A JPWO2021177333A1 JP WO2021177333 A1 JPWO2021177333 A1 JP WO2021177333A1 JP 2022504415 A JP2022504415 A JP 2022504415A JP 2022504415 A JP2022504415 A JP 2022504415A JP WO2021177333 A1 JPWO2021177333 A1 JP WO2021177333A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022504415A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021177333A1 publication Critical patent/JPWO2021177333A1/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
JP2022504415A 2020-03-03 2021-03-03 Pending JPWO2021177333A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020035579 2020-03-03
PCT/JP2021/008063 WO2021177333A1 (ja) 2020-03-03 2021-03-03 アディポネクチンの定量方法及びそれに用いる分析用試薬

Publications (1)

Publication Number Publication Date
JPWO2021177333A1 true JPWO2021177333A1 (ja) 2021-09-10

Family

ID=77613534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504415A Pending JPWO2021177333A1 (ja) 2020-03-03 2021-03-03

Country Status (5)

Country Link
US (1) US20230243855A1 (ja)
EP (1) EP4116711A4 (ja)
JP (1) JPWO2021177333A1 (ja)
CN (1) CN115485554A (ja)
WO (1) WO2021177333A1 (ja)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06231307A (ja) 1993-02-02 1994-08-19 Hitachi Ltd 光学式文字認識方式
AU693289B2 (en) 1994-11-30 1998-06-25 Nippon Chemiphar Co. Ltd. Denatured low-density lipoprotein receptor
EP1627229A2 (en) * 2003-04-29 2006-02-22 Cytos Biotechnology AG Methods and compositions for modulating the interaction between adiponectin and its receptor
ES2320139T3 (es) * 2003-12-03 2009-05-19 Whitehead Institute For Biomedical Research Uso de t-cadherina soluble para el tratamiento de trastornos metabolicos.
JP5380303B2 (ja) 2007-12-14 2014-01-08 大塚製薬株式会社 高分子アディポネクチン測定法
JP5706669B2 (ja) 2010-11-10 2015-04-22 独立行政法人国立循環器病研究センター 融合タンパク質、核酸、ベクター、細胞、ｌａｂの測定方法、並びに、ｌａｂ測定用キット
WO2013190679A1 (ja) * 2012-06-21 2013-12-27 独立行政法人国立循環器病研究センター 融合タンパク質、核酸、ベクター、細胞、ｌａｂの測定方法、並びに、ｌａｂ測定用キット
US20160195551A1 (en) * 2013-09-03 2016-07-07 Kazuhisa Maeda Method for evaluating salivary adiponectin level and kit for measuring salivary adiponectin level
JP5581432B2 (ja) * 2013-09-17 2014-08-27 株式会社バイオマーカーサイエンス 脳卒中又は脳梗塞の発症リスクの評価方法及び評価用キット
JPWO2017006431A1 (ja) * 2015-07-07 2018-04-19 有限会社ガッテン バイオマーカーの検出方法及び検出キット
JP6618079B2 (ja) * 2016-01-29 2019-12-11 国立大学法人大阪大学 エクソソーム産生促進剤
JP7365050B2 (ja) * 2018-02-14 2023-10-19 達也 沢村 融合タンパク質、及びそれを用いた高密度リポタンパク質の測定キット

Also Published As

Publication number Publication date
EP4116711A1 (en) 2023-01-11
US20230243855A1 (en) 2023-08-03
WO2021177333A1 (ja) 2021-09-10
CN115485554A (zh) 2022-12-16
EP4116711A4 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112021014123A2 (ja)
BR112023012656A2 (ja)
JPWO2022250009A1 (ja)
BR112022024743A2 (ja)
BR112022009896A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR112021017747A2 (ja)
BR102021012571A2 (ja)
BR102021012230A2 (ja)
BR102021012003A2 (ja)
BR102021012107A2 (ja)
BR112021013417A2 (ja)
BR102021010467A2 (ja)

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20230519

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231212